Measuring KPIs is critical. Nothing really new...how you do it and even more importantly: what can you learn and how do you apply is much more challenging. Learn more from this case study on what has worked for one of our clients:
Follow
MDoutlook
@mdoutlook
Innovative and leading precision intelligence organization. Powered by own platform, we work globally with life science organizations, clinicians and experts
MDoutlook’s Tweets
Welcome to Atlanta!
Quote Tweet
The Netherlands and the United States: a partnership that works in Tennessee, North Carolina, South Carolina, Alabama, and Georgia!
We’re open for business → netherlandsworldwide.nl/countries/unit #NLinAtlanta
1:19
1.1K views
Thrilled to launch ONCpulse. Our new solution delivers rapid, on-demand insights for improved decision-making. Check it out:
Which clinical data announcements will resonate most with oncologists at the 2018 #ASCO conference? Learn how MDoutlook’s Oncology Conference Insights offering can provide you with that insight.
1
1
Oncology pharma companies are not getting the needed market intelligence. bit.ly/2ENvgeP MDoutlook clients share their informational needs. bit.ly/2CeteXF
Are oncology drug companies investing billions in new therapies based on suspect oncologist data? MDoutlook CEO, Jan Heybroek, addresses this rising industry concern in his latest blog bit.ly/2Gi5dwP. Share your feedback with Jan at Jan.Heybroek@MDoutlook.com.
1
New GI Cancer Report published: impact of latest data from ASCO2016: mdoutlook.com/2016/06/23/pos
Fascinating read. MDoutlook is supporting clients focusing on these 12 innovations. worldmedicalinnovation.org/disruptive-doz
Growing cancer survival due to better treatments and diagnosis: continues to 2026 onlinelibrary.wiley.com/enhanced/doi/1
What are oncologists excited about 2016? Learn more from our proprietary research: mdoutlook.com/2016/06/01/asc
Updates on the National Cancer Moonshot at ASCO: am.asco.org/national-cance
Reality-based market sizing with patient/physician segmenting, referral patterns is key to cancer commercialization: tinyurl.com/j882z66
2
56
48
Call for abstracts: The Palliative Care in Oncology Symposium is accepting abstracts until May 24 bit.ly/SDL4IX #PallOnc
7
1
5
1
MDoutlook takes a fresh look at segmentation for meaningful targeting and commercialization in cancer: mdoutlook.com/2016/05/11/rel
MDoutlook analyzes impact of new data presented in AML: mdoutlook.com/2016/03/25/imp
MDoutlook grows: Join our team as Global Medical Analyst and make a difference to the management of cancer. mdoutlook.com/2016/03/11/joi
Interesting and compelling article in Sunday Magazine of NY Times: mdoutlook.com/2016/05/14/imm
I'm hiring! Global Medical Analyst at MDoutlook - Greater Atlanta Area #jobs
lnkd.in/DJXWGb Hi everyone, I run MDoutlook, a disease intelligence organization with a strong track record in providing insight...
Asco2013: exciting to see what new research advances cancer treatment. We'll be doing our oncopolls directly following.